admin
Medtalks with Dr KK Aggarwal
healthysoch
New Delhi, April 24, 2019 :
1.Older adults with end-stage kidney disease who start dialysis–a treatment that keeps their blood free of toxins–appear to die at higher rates than previously thought, according to findings of a new study by researchers at Harvard Medical School, Brigham and Women’s Hospital, Veterans Affairs Boston Healthcare System and Icahn School of Medicine at Mount Sinai, among other institutions. More than half of older adults who started dialysis died within a year of beginning treatment, according to the research, and nearly one in four succumbed to the disease within a month of doing so.
2.Universal screening is better in diagnosing woman with hemoglobinopathies. Carrier screening for thalassemia should be offered to all pregnant women attending antenatal clinic during early pregnancy.
3.The US Food and Drug Administration (FDA) has granted marketing authorization to NeuroSigma for its Monarch external trigeminal nerve stimulation (eTNS) system. It is the first device to treat attention-deficit/
4.The World Health Organization is pleased to announce the staging of the second edition of the “Walk the Talk: The Health for All Challenge” event on Sunday 19 May 2019 in Geneva.
5.WHO calls on everyone to be inspired by the global movement to achieve universal health coverage (UHC), i.e. achieving better health and well-being for all people at all ages, including financial risk protection, access to quality essential health care services and access to safe, effective, quality and affordable essential medicines and vaccines for all. Infection Prevention and Control, including hand hygiene, is critical to achieve UHC as it is a practical and evidence-based approach with demonstrated impact on quality of care and patient safety across all levels of the health system.
6.The current recommendation is that primary prevention with aspirin is appropriate for most patients over age 40, but now advise that the decision whether to use aspirin for primary prevention of cardiovascular disease and cancer be made based on shared decision-making, taking into account the probable benefits and harms of aspirin relative to the specific patient.
healthy soch
HealthySoch
